This inventor holds 102 USPTO granted patents and 39 published patent applications, plus 1 CIPO patent and 22 EPO patents, primarily in Continuous Glucose Monitoring (CPC class A61B5-14532). Top assignees: Dexcom, Inc., Medtronic Minimed, Inc., Companion Medical, Inc.. Active years: 1991-2026.
Inventors with similar research interests:
Location History:
- New York, NY (US) (2012)
- Miami, FL (US) (1991 - 2013)
- Henderson, NC (US) (2019)
- Seattle, WA (US) (2019)
- San Diego, CA (US) (2016 - 2024)
Company Filing History:
92 out of 1,021 
4 out of 1,262 
1 out of 12 
Years Active: 1991-2026
Areas of Expertise:
Title: The Innovative Journey of Eric Cohen in Glucose Monitoring Technologies
Introduction
Eric Cohen, based in San Diego, CA, has established himself as a prominent inventor in the field of medical technology. With an impressive portfolio of 92 patents, Cohen's contributions focus primarily on innovations related to glucose monitoring systems, which play a crucial role in diabetes management and healthcare technology.
Latest Patents
Cohen's latest patents showcase his commitment to enhancing the accessibility and security of glucose data. One notable invention is centered around systems and methods for distributing continuous glucose data. This patent outlines innovative mechanisms for receiving biosensor data from medical devices, particularly focusing on glucose concentration values. It includes features for monitoring glucose levels, displaying relevant data, and managing the distribution of this information across various applications on devices like smartphones. Another significant patent pertains to a continuous glucose monitor capable of wirelessly transmitting data to multiple display devices. This system incorporates security measures, including hashing techniques and changing application keys, to ensure secure communications between transmitters and displays, while also coordinating commands and data updates across devices.
Career Highlights
Throughout his career, Eric Cohen has contributed his expertise to leading companies in the medical technology sector. He has notably worked with Dexcom, Inc. and Medtronic Minimed, Inc., where his inventions have advanced the capabilities of continuous glucose monitoring and related technologies. His dedication to innovation has led to significant improvements in how glucose data is managed and utilized in healthcare settings.
Collaborations
Cohen's journey has included collaborations with talented professionals such as Michael Robert Mensinger and Eli Reihman. Together, they have pushed the boundaries of medical technology, combining their skills to develop cutting-edge solutions for glucose monitoring and data management.
Conclusion
Eric Cohen's innovative work in glucose monitoring systems underscores the importance of technology in improving healthcare outcomes. His 92 patents reflect a career devoted to advancing medical technology, particularly in diabetes management. As he continues to innovate, the potential impact of his inventions will undoubtedly enhance the quality of life for countless individuals managing glucose levels.